{"Title": "Individualising therapy for drug-sensitive tuberculosis", "Year": 2019, "Source": "Lancet Respir. Med.", "Volume": "7", "Issue": 10, "Art.No": null, "PageStart": 834, "PageEnd": 835, "CitedBy": 1, "DOI": "10.1016/S2213-2600(19)30247-4", "Link": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85072372732&origin=inward", "Abstract": null, "AuthorKeywords": null, "IndexKeywords": ["Antitubercular Agents", "Drug Resistance, Microbial", "Drug Therapy, Combination", "Ethambutol", "Humans", "Isoniazid", "Microbial Sensitivity Tests", "Mycobacterium tuberculosis", "Precision Medicine", "Pyrazinamide", "Rifampin", "Tuberculosis, Pulmonary"], "DocumentType": "Journal", "PublicationStage": null, "OpenAccess": 2, "EID": "2-s2.0-85072372732", "SubjectAreas": [["Pulmonary and Respiratory Medicine", "MEDI", "2740"]], "AuthorData": {"20433723200": {"Name": "Esmail H.", "AuthorID": "20433723200", "AffiliationID": "60000356", "AffiliationName": "Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Diseases and Molecular Medicine, University of Cape Town"}, "7102771386": {"Name": "Nunn A.", "AuthorID": "7102771386", "AffiliationID": "60022148, 60015879", "AffiliationName": "Medical Research Council Clinical Trials Unit, University College London"}, "57195311478": {"Name": "Lipman M.C.", "AuthorID": "57195311478", "AffiliationID": "60022148", "AffiliationName": "University College London Respiratory, Division of Medicine, University College London"}, "55562321300": {"Name": "Walker T.M.", "AuthorID": "55562321300", "AffiliationID": "60008936, 60026851", "AffiliationName": "Nuffield Department of Medicine, University of Oxford"}}}